Ownership history in ALGERT GLOBAL LLC · 7 quarters on record
This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in THERAVANCE BIOPHARMA INC (TBPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 199,705 | +94,096 | +89.1% | 0.05% | $2.9M | $14.60 |
| 2024 Q3 | ADDED | 105,609 | +74,909 | +244.0% | 0.02% | $851K | $8.06 |
| 2022 Q3 | REDUCED | 30,700 | -39,190 | -56.1% | 0.02% | $311K | $10.14 |
| 2022 Q2 | ADDED | 69,890 | +49,160 | +237.1% | 0.05% | $633K | $9.06 |
| 2022 Q1 | REDUCED | 20,730 | -11,000 | -34.7% | 0.01% | $198K | $9.56 |
| 2021 Q4 | ADDED | 31,730 | +13,350 | +72.6% | 0.04% | $351K | $11.05 |
| 2021 Q3 | INITIATED | 18,380 | — | — | 0.02% | $136K | $7.40 |
As of 2025 Q4 — sorted by position size